Eli Lilly will spend at least $27 billion dollars to build four manufacturing plants in the U.S. in order to move production back to America.

Eli Lilly and Company said Wednesday they plan to build new pharmaceutical manufacturing sites in the United States.

Eli Lilly plans to invest $27 billion in four new pharmaceutical manufacturing facilities in the U.S., expanding its domestic production of medications across multiple therapeutic areas. The ...

Healthcare company stocks ended lower on a rough day for biotech companies and medical providers. Molina Healthcare and Centene notched big declines the day after a House budget resolution threatened ...

Eli Lilly and Company is expanding its U.S. pharmaceutical manufacturing capabilities with four new facilities, a move that ...

At a press conference in Washington, D.C., Eli Lilly And Co (NYSE:LLY) announced its plans to bolster its domestic medicine ...

Eli Lilly said it plans to build three new plants in the U.S. to make the key ingredients used in pharmaceuticals, part of a ...

Eli Lilly & Co.’s stock rose 1.6% Wednesday, after the drug company announced plans to expand its U.S. manufacturing sites by ...

The new plants will be built over the next five years, and are expected to create more than 3,000 jobs for skilled workers.

Pharmaceutical giants like Eli Lilly and Grifols report significant investment and growth. In the U.S., Eli Lilly plans a $27 billion investment in manufacturing plants, while Grifols reports a 10% ...

Pharmaceutical giant expects the move will create 3,000 high-skilled jobs and provide work for approximately 10,000 ...

The Indianapolis-based pharmaceutical company announced plans for four new manufacturing sites, but has not decided where ...